{
    "N/R/U": null,
    "Applicant": "Kite Pharma Inc.",
    "BLA Number": "125703",
    "Proprietary Name": "Tecartus",
    "Proper Name": "Brexucabtagene Autoleucel",
    "BLA Type": "351(a)",
    "Strength": "2Ã—10^6 CAR-positive viable T cells per kg body weight ",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Bag",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "24-Jul-20",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2064",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "1-Oct-28"
}